Lipoprotein docosapentaenoic acid is associated with serum matrix metalloproteinase-9 concentration

Lipids in Health and Disease

Volumn 4, Issue , 2005, Pages

  Solakivi, Tiina ^a   Jaakkola, Olli ^a,b   Kalela, Anne ^a   Pispa, Mari ^c   Salomäki, Anne ^c   Lehtimäki, Terho ^a,c   Höyhtyä, Matti ^d   Jokela, Hannu ^c   Nikkari, Seppo T ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d NONE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; DOCOSAPENTAENOIC ACID; GELATINASE B; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID COMPOSITION;

ADULT; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPOPROTEINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED;

EID: 21444438812     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-4-8     Document Type: Article

References (21)

1. Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL: Elevated levels of 92-kD type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996, 39:1747-1753.
2. Nikkari ST, Hoyhtya M, Isola J, Nikkari T: Macrophages contain 92-kD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996, 149:1427-33.
3. Kalela A, Koivu TA, Sisto T, Kanervisto J, Hoyhtya M, Sillanaukee P, Lehtimaki T, Nikkari ST: Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest 2002, 62:337-42.
4. Sonnante AM, Correale M, Linsalata M, Di Leo A, Guerra V: Circulating levels of matrix metalloproteinase-9 in patients with colorectal cancer. Scand J Gastroenterol 2000, 35:671-72.
5. Belleguic C, Corbel M, Germain N, Lena H, Boichot E, Delaval PH, Lagente V: Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 2002, 32:217-23.
6. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ: Expression of matrix metalloproteinase 9 (96-kd gelatinase b) in human rheumatoid arthritis. Arthritis Rheum 1996, 39:1576-87.
7. Mohrhauer H, Christiansen K, Gan MV, Deubig M, Holman RT: Chain elongation of linoleic acid and its inhibition by other fatty acids in vitro. J Biol Chem 1967, 242:4507-14.
8. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H: Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 1979, 76:944-48.
9. Dyerberg J, Bang HO: A hypothesis on the development of acute myocardial infarction in greenlanders. Scand J Clin Labs Invest 1982:7-13.
10. Belluzzi A: N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 2002, 61:391-95.
11. Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, Gonzalez-Huix F, Moreno J, Humbert P, Guilera M: Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 33:1365-69.
12. Esteve-Comas M, Nunez MC, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, Gonzalez-Huix F, Bertran X, Gassull MA: Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993, 34:1370-73.
13. Geerling BJ, v Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ: Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with crohn's disease, compared with controls. Am J Gastroenterol 1999, 94:410-17.
14. Buhner S, Nagel E, Korber J, Vogelsang H, Linn T, Pichlmayr R: Ileal and colonic fatty acid profiles in patients with active crohn's disease. Gut 1994, 35:1424-8.
15. Trebble TM, Arden NK, Wootton SA, Mullee MA, Calder PC, Burdge GC, Fine DR, Stroud MA: Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin Nutr 2004, 23:647-55.
16. Nieto N, Giron MD, Suarez MD, Gil A: Changes in plasma and colonic mucosa fatty acid profiles in rats with ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci 1998, 43:2688-95.
17. Jacobsson L, Lindgarde F, Manthorpe R, Akesson B: Correlation of fatty acid composition of adipose tissue lipids and serum phosphatidylcholine and serum concentrations of micronutrients with disease duration in rheumatoid arthritis. Ann Rheum Dis 1990, 49:901-5.
18. Kalela A, Koivu TA, Sisto T, Kanervisto J, Hoyhtya M, Sillanaukee P, Lehtimaki T, Nikkari ST: Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest 2002, 62:337-42.
19. Sprecher H: Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 2000, 1486:219-31.
20. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-715.
21. Wahl LM, Corcoran ML: Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol 1993, 64:467-73.